Abstract
Episodic ataxias (EA) are rare autosomal dominant channelopathies characterized by recurrent episodes of ataxia, vertigo and incoordination. So far, eight subtypes have been described with identified gene mutations in five of them (EA1, EA2, EA5, EA6 and EA8). Clinical clues, for example precipitating triggers, duration of attacks, associated interictal signs and treatment response, can aid the distinction of the different subtypes of EA. The current chapter will give an overview of clinical symptoms, genetic background and treatment for the different subtypes of EA. It will also briefly discuss the clinico-genetic characteristics of further disorders that may present with recurring bouts of paroxysmal ataxia and may, therefore, fall within the episodic ataxia spectrum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15(3):369–91.
Klockgether T, Paulson H. Milestones in ataxia. Mov Disord. 2011;26(6):1134–41.
Guterman EL, Yurgionas B, Nelson AB. Pearls & Oy-sters: episodic ataxia type 2: case report and review of the literature. Neurology. 2016;86(23):e239–41.
VanDyke DH, Griggs RC, Murphy MJ, Goldstein MN. Hereditary myokymia and periodic ataxia. J Neurol Sci. 1975;25(1):109–18.
Graves TD, Cha YH, Hahn AF, Barohn R, Salajegheh MK, Griggs RC, et al. Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation. Brain. 2014;137(Pt 4):1009–18.
Tomlinson SE, Rajakulendran S, Tan SV, Graves TD, Bamiou DE, Labrum RW, et al. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. J Neurol Neurosurg Psychiatry. 2013;84(10):1107–12.
Rajakulendran S, Schorge S, Kullmann DM, Hanna MG. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics. 2007;4(2):258–66.
Romaniello R, Zucca C, Tonelli A, Bonato S, Baschirotto C, Zanotta N, et al. A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J Neurol Neurosurg Psychiatry. 2010;81(8):840–3.
Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology. 2004;62(1):17–22.
Molloy A, Kimmich O, Martindale J, Moore H, Hutchinson M, O’Riordan S. A novel CACNA1A mutation associated with adult-onset, paroxysmal head tremor. Mov Disord. 2013;28(6):842–3.
Vighetto A, Froment JC, Trillet M, Aimard G. Magnetic resonance imaging in familial paroxysmal ataxia. Arch Neurol. 1988;45(5):547–9.
Lee H, Jang DH, Jang JH, Kim T. Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation. Eur J Neurol. 2017;24(7):e43–e4.
Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011;77(3):269–75.
Sintas C, Carreno O, Fernandez-Castillo N, Corominas R, Vila-Pueyo M, Toma C, et al. Mutation spectrum in the CACNA1A gene in 49 patients with episodic ataxia. Sci Rep. 2017;7(1):2514.
Pradotto L, Mencarelli M, Bigoni M, Milesi A, Di Blasio A, Mauro A. Episodic ataxia and SCA6 within the same family due to the D302N CACNA1A gene mutation. J Neurol Sci. 2016;371:81–4.
Cader MZ, Steckley JL, Dyment DA, McLachlan RS, Ebers GC. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology. 2005;65(1):156–8.
Steckley JL, Ebers GC, Cader MZ, McLachlan RS. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology. 2001;57(8):1499–502.
Farmer TW, Mustian VM. Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations. Arch Neurol. 1963;8:471–80.
Damji KF, Allingham RR, Pollock SC, Small K, Lewis KE, Stajich JM, et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol. 1996;53(4):338–44.
Merrill MJ, Nai D, Ghosh P, Edwards NA, Hallett M, Ray-Chaudhury A. Neuropathology in a case of episodic ataxia type 4. Neuropathol Appl Neurobiol. 2016;42(3):296–300.
Escayg A, De Waard M, Lee DD, Bichet D, Wolf P, Mayer T, et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet. 2000;66(5):1531–9.
Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology. 2005;65(4):529–34.
de Vries B, Mamsa H, Stam AH, Wan J, Bakker SL, Vanmolkot KR, et al. Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. Arch Neurol. 2009;66(1):97–101.
Choi KD, Jen JC, Choi SY, Shin JH, Kim HS, Kim HJ, et al. Late-onset episodic ataxia associated with SLC1A3 mutation. J Hum Genet. 2017;62(3):443–6.
Iwama K, Iwata A, Shiina M, Mitsuhashi S, Miyatake S, Takata A, et al. A novel mutation in SLC1A3 causes episodic ataxia. J Hum Genet. 2018;63(2):207–11.
Kerber KA, Jen JC, Lee H, Nelson SF, Baloh RW. A new episodic ataxia syndrome with linkage to chromosome 19q13. Arch Neurol. 2007;64(5):749–52.
Conroy J, McGettigan P, Murphy R, Webb D, Murphy SM, McCoy B, et al. A novel locus for episodic ataxia:UBR4 the likely candidate. Eur J Hum Genet. 2014;22(4):505–10.
Sweney MT, Newcomb TM, Swoboda KJ. The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism, CAPOS and beyond. Pediatr Neurol. 2015;52(1):56–64.
Demos MK, van Karnebeek CD, Ross CJ, Adam S, Shen Y, Zhan SH, et al. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis. 2014;9:15.
Chang IJ, Adam MP, Jayadev S, Bird TD, Natarajan N, Glass IA. Novel pregnancy-triggered episodes of CAPOS syndrome. Am J Med Genet A. 2018;176(1):235–40.
Stagnaro M, Pisciotta L, Gherzi M, Di Rocco M, Gurrieri F, Parrini E, et al. ATP1A3 spectrum disorders: a video-documented history of 7 genetically confirmed early onset cases. Eur J Paediatr Neurol. 2018;22(2):264–71.
Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138(Pt 12):3476–95.
Gardiner AR, Bhatia KP, Stamelou M, Dale RC, Kurian MA, Schneider SA, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology. 2012;79(21):2115–21.
Dmitry Tchapyjnikov, Mohamad A. Mikati, Acetazolamide-responsive Episodic Ataxia Without Baseline Deficits or Seizures Secondary to GLUT1 Deficiency. The Neurologist. 23(1):17–18.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Characteristic interictal myokymia in a patient with genetically confirmed EA1 (MOV 10757 kb)
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zittel, S., Ganos, C. (2021). Episodic Ataxias. In: Sethi, K.D., Erro, R., Bhatia, K.P. (eds) Paroxysmal Movement Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-53721-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-53721-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53720-3
Online ISBN: 978-3-030-53721-0
eBook Packages: MedicineMedicine (R0)